Anthem Blue Cross Connecticut Commercial Clinical Policy

Anthem Blue Cross Connecticut SURG.00153 Cardiac Contractility Modulation Therapy Form

Effective Date

09/27/2023

Last Reviewed

08/10/2023

Original Document

  Reference



This document addresses the use of cardiac contractility modulation therapy designed to treat chronic moderate-to-severe heart failure.

Note: Please see the following related document for additional information:

  • CG-SURG-63 Cardiac Resynchronization Therapy with or without an Implantable Cardioverter Defibrillator for the Treatment of Heart Failure

Position Statement

Investigational and Not Medically Necessary:

The use of cardiac contractility modulation therapy is considered investigational and not medically necessary for all indications, including but not limited to heart failure.